BioPredict

BioPredict, Inc. is a computational biotechnology company specializing in advanced molecular modeling and simulation for drug discovery. Founded by Dr. Ronald Levy, the company utilizes sophisticated statistical mechanics and molecular dynamics algorithms to predict protein-ligand binding affinities and structural interactions with high precision. Their proprietary technology, including the AGBNP implicit solvent model and the BEDAM binding energy method, aims to accelerate the lead optimization process by providing high-accuracy physical models of molecular recognition. BioPredict's services and software tools support pharmaceutical and biotechnology partners in identifying and refining potential therapeutic candidates across various therapeutic areas, including oncology and immunology. The company's platform is designed to provide detailed thermodynamic and kinetic insights into molecular binding, facilitating the rational design of novel small molecule therapeutics.